COMPANY PROFILE

Shenzhen Letu Precision Medical Technology

Explore full profile

Pioneering molecular diagnostics for oncology, reproductive health, and overall wellbeing in China

Ningbo, ChinaFounded 2016Biotech & Life Sciences

Valuation $500M–1B Latest valuation · 2023

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Shenzhen Letu Precision Medical Technology

Shenzhen Leatherland Precision Medical Corporation, operating under the brand Leather Life Technology, is at the forefront of integrating advanced biomedical technologies and products. The company specializes in molecular diagnostic techniques, offering development, production, marketing, and clinical testing services. Their primary focus areas include oncology, reproductive health, and general wellbeing, serving a diverse clientele ranging from individual patients to large healthcare institutions in China. Leather Life Technology collaborates with renowned institutions like CVP to develop precision medical consultation systems and aims to establish leading medical centers. The business model revolves around providing high-quality diagnostic services and leveraging cutting-edge research to enhance patient outcomes. Revenue is generated through the sale of diagnostic products and services, as well as partnerships with healthcare providers and research institutions.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Ningbo, China
Open positions: None listed
Dealroom signal: 21.3/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Oncology, Genetics and genomics, Precision Medicine, Health Diagnostics, Femtech, Reproductive Health, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Latest news

Press, funding announcements and product moves mentioning Shenzhen Letu Precision Medical Technology.

See all news

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Oct 2023	$138M	$550M	CICC	↗
SERIES AOther financing	Dec 2020	—	—	CICC	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shenzhen Letu Precision Medical Technology website traffic

Latest recorded traffic for Shenzhen Letu Precision Medical Technology is 120 monthly website visits, down 89.1% over the last three months.

Latest monthly visits120 3-month web change-89.1%

Monthly website visitsOct 2023–Apr 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AQAqtualProviding advanced precision medicine products in the costliest disease areas	Hayward, United States	Operational	35	$47M	$124M
BIBiofidelityRapid genomic biomarker detection for precision oncology	Cambridge, United Kingdom	Operational
DPDiatech PharmacogeneticsProvider of molecular diagnostic tools for precision medicine.	Jesi, Italy	Operational
BOBerry OncologyGenomic testing and early screening for cancer	Fuzhou City, China	Operational
LYLynsightMedical devices company committed to reducing cancer mortality rates with a simple diagnostic method that reliably detects an inherited cancer-causing condition prior to cancer	Helsinki, Finland	Operational
ATADmit TherapeuticsEpigenetic blood test for early Alzheimer's prognosis	Esplugues de Llobregat, Spain	Operational
THTherapySelectProvides diagnostic services for personalized cancer treatment	Heidelberg, Germany	Operational
OPOphiomicsOphiomics develops bioinformatics/genomics-based diagnostic products and services for liver cancer diagnosis, prognosis and follow-up.	Lisbon, Portugal	Operational

Showing 8 of the closest matchesCompare every metric →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

CICICC

Talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

🇨🇳 China · Ningbo HQ

Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shenzhen Letu Precision Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shenzhen Letu Precision Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.